Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories.
Rhesus monkeys lever-pressed under a fixed-ratio 30 time-out 600 sec schedule of i.v. injection of codeine (0.32 mg/kg/injection) or, in a second group of monkeys, ketamine (1.0 mg/kg/injection). During single session substitutions, the maintenance drug was replaced with saline or doses of various other drugs. At appropriate doses, ketamine maintained responding when substituted for ketamine. Phencyclidine, dexoxadrol and dextrorphan maintained responding when substituted for ketamine but did not maintain responding when substituted for codeine. Cyclazocine and SKF-10,047 (N-allyl-normetazocine) did not maintain responding when substituted for either ketamine or codeine; ethylketazocine did not maintain responding when substituted for ketamine. For those drugs maintained under behavior, fixed-ratio response rate and the number of injection dose and then decreased at higher injection doses. Substituted drugs maintained maximum response rates at the following injection doses: codeine, 0.32 mg/kg; ketamine, 1.0 mg/kg; phencyclidine, 0.03 mg/kg, dexoxadrol, 0.32 mg/kg; and dextrorphan, 1.0 mg/kg. Under only the ketamine maintenance schedule, the rate of responding during the timeout component varied as a function of the substitution dose of ketamine, codeine, phencyclidine and dexoxadrol, with the dose that maintained maximal fixed-ratio rates also engendering the highest rates of timeout responding.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D003061:Codeine / Q000494:pharmacology; D007649:Ketamine / Q000494:pharmacology*; D008253:Macaca mulatta; D008297:Male; D009292:Narcotic Antagonists / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology; D010622:Phencyclidine / Q000494:pharmacology; D012055:Reinforcement Schedule; D012646:Self Administration
D009292:Narcotic Antagonists; D009294:Narcotics; D007649:Ketamine; D010622:Phencyclidine; D003061:Codeine